Takeda Pharmaceutical
TAK
#418
Rank
A$83.88 B
Marketcap
A$26.55
Share price
0.65%
Change (1 day)
25.37%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): A$4.93 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.86 Billion. , an increase over its 2024 earnings that were of A$3.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 A$4.73 B49.03%
2024 A$3.17 B-2.41%
2023 A$3.25 B-28.14%
2022 A$4.52 B-40.9%
2021 A$7.66 B78.24%
2020 A$4.29 B246.1%
2019 A$1.24 B-48.79%
2018 A$2.42 B-23.64%
2017 A$3.17 B21.7%
2016 A$2.60 B-253.01%
2015 -A$1.71 Billion-159.65%
2014 A$2.85 B13%
2013 A$2.52 B2.46%
2012 A$2.46 B-57.05%
2011 A$5.74 B-10.49%
2010 A$6.42 B-3.99%
2009 A$6.68 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.09 B 874.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$23.26 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.86 B 256.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.73 B 147.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$12.94 B 173.64%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$32.85 B 594.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.26 B 180.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.13 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$1.24 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India